Lombard Medical Technologies (NSDQ:EVAR) said today it won CE Mark approval in the European Union for its IntelliFlex low profile delivery system for its Aorfix endovascular stent graft. The system is designed for the delivery of the company’s abdominal aortic aneurysm Aorfix endovascular stent graft, and includes an integrated exchange sheath designed for the delivery of […]
lombardmedical
Lombard touts 5-year Aorfix stent graft data
Lombard Medical Technologies (NSDQ:EVAR) yesterday released 5-year results from the Pythagoras trial of its Aorfix, which aimed to evaluate the safety and effectiveness of the stent graft in treating highly angulated aortic necks or tortuous aortoiliac anatomy. A presentation based on data from the study was presented at the 2016 Society for Vascular Surgery’s annual meeting […]
Lombard rises on prelims, expanding EU sales force and US drill down
Lombard Medical Technologies (NSDQ:EVAR) yesterday released preliminary estimates for its Q4 and fiscal year 2015, off slightly from estimates but shares rose with the news. The Irvine, Calif.-based company reported preliminary revenue of $2.9 million for the quarter and $15.1 million fro the full year – a growth of 14% from last year, but off of Wall […]
Philips Healthcare’s India chief takes over new emerging markets biz | Personnel Moves
Royal Philips (NYSE:PHG) has promoted its India managing director and CEO Krishna Kumar to a position managing its emerging healthcare business division, according to The Times of India. Kumar is slated to continue as managing director of Philips India division until December, at which point he will lead the development of consumer and profesisonal healthcare […]
Lombard purchases endograft developer Altura
Lombard Medical Technologies (NSDQ:EVAR) said today it acquired endovascular stent graft developer Altura Medical. Altura develops ultra-low profile endovascular stent graft technology intended for the treatment of abdominal aortic aneurysms, in line with Lombard’s own technologies and their flagship Aorfix endograft. The terms of the transaction between Irvine, Calif.-based Lombard and Silicon Valley-based Altura medical included the […]
Lombard Medical looks to M&A to grow beyond AorFix
Lombard Medical Technologies (NSDQ:EVAR) CEO Simon Hubbert this week said the stent graft maker is looking beyond the abdominal aortic aneurysm repair market, aiming to grow out of being a 1-product company either via acquisition or a distribution deal with a larger medical device company. Discussing Lombard’s 2nd-quarter results July 27, Hubbert referenced the $110 million buyout of Aptus Endosystems […]
Lombard Medical debuts latest Aorfix stent graft
Lombard Medical Technologies (NSDQ:EVAR) today announced the debut of its Aorfix Plus stent graft for endovascular repair of abdominal aortic aneurysms. The Aorfix Plus, designed to treat larger-size AAAs, won 510(k) clearance from the FDA for the device in February. Irvine, Calif.-based Lombard said the 1st clinical cases using the device were successfully completed at sites including the […]
GPOs: Lombard Medical inks supply deal with Novation
Lombard Medical Technologies (NSDQ:EVAR) said today that it inked a 3-year supply deal with Novation for its Aorfix endovascular stent graft. Irving, Texas-based Novation is a group purchasing organization that serves more than 100,000 members and affiliates in the U.S., Lombard said, including VHA Inc., UHC, Children’s Hospital Assn. and Provista LLC. "Based on a thorough […]